Features and properties of ganciclovir ophthalmic gel and acyclovir... | Download Scientific Diagram
![Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram](https://www.researchgate.net/publication/263741672/figure/fig4/AS:601726327480332@1520474144884/Phosphorylation-activation-of-ACV-and-ganciclovir-by-viral-kinases-Upon-administration.png)
Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram
![PDF] In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. | Semantic Scholar PDF] In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02e33cb2394a2fd7d3f065cb6ea74a5e6369b05b/2-Table1-1.png)
PDF] In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. | Semantic Scholar
![Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines | Gene Therapy Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.gt.3301779/MediaObjects/41434_2002_Article_BF3301779_Fig1_HTML.jpg)
Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines | Gene Therapy
![Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation | Bone Marrow Transplantation Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bmt.1703770/MediaObjects/41409_2002_Article_BF1703770_Fig1_HTML.jpg)
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation | Bone Marrow Transplantation
![Aciclovir Ganciclovir Chemical structure Structural formula, Pom pom purin transparent background PNG clipart | HiClipart Aciclovir Ganciclovir Chemical structure Structural formula, Pom pom purin transparent background PNG clipart | HiClipart](https://p7.hiclipart.com/preview/327/273/293/aciclovir-ganciclovir-chemical-structure-structural-formula-pom-pom-purin.jpg)
Aciclovir Ganciclovir Chemical structure Structural formula, Pom pom purin transparent background PNG clipart | HiClipart
![Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram](https://www.researchgate.net/publication/263741672/figure/fig5/AS:601726327455765@1520474144912/Phosphorylation-activation-of-ACV-and-ganciclovir-by-viral-kinases-Upon-administration.png)
Phosphorylation activation of ACV and ganciclovir by viral kinases.... | Download Scientific Diagram
![In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates | Revista Argentina de Microbiología In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates | Revista Argentina de Microbiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//03257541/0000005000000004/v1_201811250605/S0325754118300051/v1_201811250605/en/main.assets/gr5.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfEV5pF+xHz5AXlqpRSzYsBvmTPf5Olxovo2JswLZ0yp2HdeKHZp3PAPhbM8yLS+xG3eUHOKI08LjEHrER0yVik3Yf5TVDZVvB3wslPDMSUU97S3ixBpspe6PcxJ0tcF8XMWSAIWIqURjVbG9KWWtxj5jxwzfTsNnK3xZCcFqU88gkXicUDy/IdjIbFB3SjG1lYXffJ1h4S+52o4PTxTQ0NOh3L/9vxNSf3JpnqCxkHvX+rOAFPEMzaGvmT2szNiEQ=)